176 related articles for article (PubMed ID: 31072797)
1. Incidence and risk factors of paediatric cystic fibrosis-related diabetes.
Perrem L; Stanojevic S; Solomon M; Carpenter S; Ratjen F
J Cyst Fibros; 2019 Nov; 18(6):874-878. PubMed ID: 31072797
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.
Olesen HV; Drevinek P; Gulmans VA; Hatziagorou E; Jung A; Mei-Zahav M; Stojnic N; Thomas M; Zolin A;
J Cyst Fibros; 2020 Mar; 19(2):321-327. PubMed ID: 31680042
[TBL] [Abstract][Full Text] [Related]
3. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
4. The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: A CF patient registry study.
Franck Thompson E; Watson D; Benoit CM; Landvik S; McNamara J
J Cyst Fibros; 2020 Mar; 19(2):316-320. PubMed ID: 31439463
[TBL] [Abstract][Full Text] [Related]
5. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
Aksit MA; Pace RG; Vecchio-Pagán B; Ling H; Rommens JM; Boelle PY; Guillot L; Raraigh KS; Pugh E; Zhang P; Strug LJ; Drumm ML; Knowles MR; Cutting GR; Corvol H; Blackman SM
J Clin Endocrinol Metab; 2020 May; 105(5):1401-15. PubMed ID: 31697830
[TBL] [Abstract][Full Text] [Related]
6. Mediation of the total effect of cystic fibrosis-related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study.
Tanner KT; Daniel RM; Bilton D; Simmonds NJ; Sharples LD; Keogh RH
Diabet Med; 2022 Nov; 39(11):e14958. PubMed ID: 36075586
[TBL] [Abstract][Full Text] [Related]
7. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
Moheet A; Moran A
J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
[TBL] [Abstract][Full Text] [Related]
8. The development of diabetes among Danish cystic fibrosis patients over the last two decades.
Knudsen KB; Mathiesen ER; Eriksen V; Skov M; Nielsen KG; Johannesen J; Pressler T
Pediatr Diabetes; 2015 May; 16(3):219-26. PubMed ID: 24891216
[TBL] [Abstract][Full Text] [Related]
9. Recent trends in cystic fibrosis-related diabetes.
Nathan BM; Laguna T; Moran A
Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):335-41. PubMed ID: 20489612
[TBL] [Abstract][Full Text] [Related]
10. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function.
Hunt WR; Helfman BR; McCarty NA; Hansen JM
J Cyst Fibros; 2016 Sep; 15(5):681-8. PubMed ID: 26817932
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: Longitudinal data from the UK CF Registry.
Frost F; Nazareth D; Shaw M; Walshaw MJ
J Cyst Fibros; 2019 Mar; 18(2):294-298. PubMed ID: 30741162
[TBL] [Abstract][Full Text] [Related]
13. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
[TBL] [Abstract][Full Text] [Related]
14. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis.
Khare S; Desimone M; Kasim N; Chan CL
J Clin Transl Endocrinol; 2022 Mar; 27():100290. PubMed ID: 34917485
[TBL] [Abstract][Full Text] [Related]
16. Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.
Hull RL; Gibson RL; McNamara S; Deutsch GH; Fligner CL; Frevert CW; Ramsey BW; Sanda S
Diabetes Care; 2018 Apr; 41(4):823-830. PubMed ID: 29437698
[TBL] [Abstract][Full Text] [Related]
17. [Italian Cystic Fibrosis Registry. Report 2011-2014].
Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2018; 42(1S1):1-32. PubMed ID: 29506377
[TBL] [Abstract][Full Text] [Related]
18. Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults.
Adler AI; Shine BS; Chamnan P; Haworth CS; Bilton D
Diabetes Care; 2008 Sep; 31(9):1789-94. PubMed ID: 18535191
[TBL] [Abstract][Full Text] [Related]
19. Demographics of glucose metabolism in cystic fibrosis.
van den Berg JM; Kouwenberg JM; Heijerman HG
J Cyst Fibros; 2009 Jul; 8(4):276-9. PubMed ID: 19467621
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of cystic fibrosis-related diabetes.
Marshall BC; Butler SM; Stoddard M; Moran AM; Liou TG; Morgan WJ
J Pediatr; 2005 May; 146(5):681-7. PubMed ID: 15870674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
